SPONSOR
Medical University Innsbruck
Total Trials
3
Recruiting
3
Phases
N/A
Conditions studied: Coronary Artery DiseaseConnective Tissue DiseasesInterstitial Lung DiseaseSystemic SclerosisChronic Lymphocytic Leukaemia (CLL)Multiple Myeloma (MM)Secondary Immunodeficiency (SID)
Medical University Innsbruck is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Coronary Artery Disease, Connective Tissue Diseases, Interstitial Lung Disease, Systemic Sclerosis.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Medical University Innsbruck
How many clinical trials has Medical University Innsbruck sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Medical University Innsbruck, of which 3 are actively recruiting participants. These trials cover conditions including Coronary Artery Disease, Connective Tissue Diseases, Interstitial Lung Disease. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Medical University Innsbruck research focus on?
Medical University Innsbruck clinical trials span Coronary Artery Disease, Connective Tissue Diseases, Interstitial Lung Disease, Systemic Sclerosis, Chronic Lymphocytic Leukaemia (CLL), and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Medical University Innsbruck clinical trial?
To participate in a Medical University Innsbruck trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Medical University Innsbruck trials with current recruitment status updated daily.
Clinical Trials by Medical University Innsbruck
NCT05931783
Recruiting
Randomized Comparison of Skeletonized Versus Pedicled Left Internal Thoracic Artery
Coronary Artery Disease
NCT04095351
Recruiting
Connective Tissue Diseases and Lung Manifestations
Connective Tissue Diseases
NCT06821880
Recruiting
Developing a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematological Patients With Secondary Immunodeficiency (SID) Across the Treatment Trajectory - The PRO SID Project
Chronic Lymphocytic Leukaemia (CLL)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology